Oral Drug Delivery Solutions

1. Multiparticulates For Modified Release Systems 1/12/2026

   Multiparticulates enable tailored drug release with improved flexibility, dose accuracy, and patient convenience, leveraging technologies like Diffucaps® for customized profiles including immediate, delayed, extended, and pulsatile delivery.

2. Formulation Strategies For Poorly Soluble Molecules 10/15/2025

   As the number of poorly soluble compounds continues to increase in the industry development pipeline, conventional formulation strategies may not be sufficient to achieve acceptable levels of solubility in the gastrointestinal tract and hence absorption into the systemic circulation.

3. Modified-Release Formulation Strategies 10/15/2025

   Learn what oral modified-release (MR) dosage forms can offer and why they continue to rise in popularity.

4. Manufacturing For Oral Solid Dose Success 6/30/2025

   Adare Pharma Solutions provides end-to-end CDMO services for oral solid dose drugs, enabling efficient development, manufacturing, and packaging with advanced technologies and global scale.

5. Battelle: 90 Years Of Innovation 3/19/2025

   Battelle, a leading nonprofit in applied science and technology, drives innovation in national security, healthcare, environment, and education while managing research labs and advancing critical discoveries.

6. Streamlining The Generic Combination Device Design Assessment Process 3/19/2025

   A new six-phase assessment process simplifies regulatory approval for generic drug-device combination products, reducing costs and timelines while maintaining safety, effectiveness, and substitutability with reference-listed drugs.

7. Formulation And Manufacturing Equipment 7/25/2024

   AustinPx offers integrated GMP manufacturing services for oral dosage forms with a full complement of analytical development and testing capabilities.

8. Battelle uLAB 3/21/2024

   This comprehensive suite of services encompasses the entire spectrum of user research, starting from the conceptualization of study designs to meticulous data analysis and comprehensive reporting.

9. Pharmaceutical Development 4/24/2023

   Developing an optimized formulation tailored to your API nanoparticles is critical to unlocking their full potential.

10. Controlled Expansion Of Supercritical Solutions (CESS®) Technology 4/24/2023

    Nanoform’s award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology is a bottom-up nanoparticle engineering approach that enables the creation of API nanoparticles and can unlock the full therapeutic potential of small molecule drugs.